Treatment approaches have shifted with the introduction of targeted agents, notably Bruton tyrosine kinase (BTK) inhibitors, ...

Ameet Patel, MD, concludes by outlining strategies to overcome operational, financial, and payer challenges in delivering advanced multiple myeloma therapies.

Sora Ely, MD, emphasized that national lung cancer screening rates remain below 10%, underscoring the urgent need for greater ...

This move is another step in Makary’s attempts to shorten FDA reviews, which started when he began his tenure last year. 3 These include mandating the use of artificial intelligence for staffers and ...

COVID-19 vaccination showed effectiveness in reducing hospitalizations and severe disease outcomes associated with the SARS-CoV-2 JN.1 lineage, according to a recent study published in JAMA Network ...

Oral Wegovy reshapes GLP-1 costs: cash pay can be cheaper, insurance pricing often matches shots, and coverage hinges on employer benefits and coding. Levin also explores the broader outlook for oral ...

The running themes of treating and preventing HIV will be highlighted early in the plenary session held on Monday morning.

Deputy Chief for Benefits Administration for the City of Philadelphia since 2015. In her role as the City’s benefits leader, Marsha brings international experience as a Human Resources professional, ...

City leaders share real-world GLP-1 coverage tactics, showing how public employers balance access, costs, and lasting ...

During her tenure as the Director of Employee Benefits, City of Wilmington, Delaware Dany B. Smith achieved remarkable ...

Prostate cancer has been of the major areas of research for radioligand therapies. Last year, Novartis officials estimated that the March 28, 2025, FDA approval for Pluvicto in metastatic ...

Higher baseline monocyte counts, along with preserved basophils and low C-reactive protein, independently predict complete remission on anti-IgE therapy for CSU.